NCT06166992View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

February 7, 2024

Study Completion Date

February 7, 2024

Conditions
Healthy
Interventions
DRUG

BI 1291583

BI 1291583

DRUG

[14C]-BI 1291583

\[14C\]-BI 1291583

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06166992 - A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body | Biotech Hunter | Biotech Hunter